Certified Advisory Corp’s Biogen BIIB Stock Holding History

Certified Advisory Corp’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-228	Closed	-$64K	–	255
2021 Q1	$64K	Buy	+228	New	+$61.5K	0.02%	315
2020 Q2	$61K	Hold	228	–	–	0.02%	273
2020 Q1	$72K	Hold	228	–	–	0.03%	235
2019 Q4	$68K	Hold	228	–	–	0.02%	273
2019 Q3	$53K	Sell	228 -170	-43%	-$39.6K	0.02%	310
2019 Q2	$93K	Hold	398	–	–	0.03%	242
2019 Q1	$94K	Hold	398	–	–	0.04%	221
2018 Q4	$120K	Hold	398	–	–	0.06%	185
2018 Q3	$141K	Hold	398	–	–	0.07%	173
2018 Q2	$116K	Hold	398	–	–	0.06%	189
2018 Q1	$108K	Buy	398 +325	+445%	+$101K	0.06%	188
2017 Q4	$23K	Buy	+73	New	+$23.4K	0.02%	344

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Certified Advisory Corp's BIIB Position: Q2 2021 in Review

Certified Advisory Corp sold out of Biogen (BIIB) in Q2 2021, closing a stake of 228 shares — an estimated $64K sold.

Certified Advisory Corp first reported a position in BIIB in Q4 2017 and held it in 12 quarters. The position peaked at $141K in Q3 2018. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Certified Advisory Corp reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Certified Advisory Corp sold 228 Biogen shares in Q2 2021, an estimated $64K.
Certified Advisory Corp first reported a position in Biogen in Q4 2017 and held it in 12 quarters.
Certified Advisory Corp's Biogen position peaked at $141K in Q3 2018.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.